YHLO News-VISION ESR Analyzer Patented in U.S.
中文版 English
News Center
News Center > YHLO News
VISION ESR Analyzer Patented in U.S.
source:admin       The deadline:2017-10-25 16:37:43
VISION, the full-automatic erythrocyte sedimentation rate (ESR) analyzer, has just been granted the United States Patent by its new and useful invention. The patent number is US009733175B2.

VISION adopts a creative method for automatically ESR analysis by using undiluted blood sample with EDTA vacuum tubes. During testing, VISION collects sample data every 10 seconds for 20 minutes with a dynamic sedimentation curve showing on the computer.

Thus, VISION overcome the defects of complex operating, long detecting time and direct contact with the blood sample of the traditional Westergren manual method while detecting the ESR as well as the problems that some existing blood sedimentation meters measure inaccurately and require a special blood sedimentation tube.

Up to now, VISION analyzers are working in hundreds of laboratories worldwide, offering convenience, accuracy and reliability.

The detailed patent certification is attached below.


CopyRight@2016 Shenzhen YHLO Biotech Co., Ltd. rights reserved
Address:Headquarter: 13th Floor, Building A1, Kexing Science Park, No.15 Keyuan Rd., Nanshan District, 518057, Shenzhen, P.R.China
Factory:No.5 Building, Lishan Industrial Area, Xinghai Road, Nanshan District, 518054,Shenzhen, China
Tel:+86-755-26473359/ Fax: +86-755-26473319

About YHLOPress NewsProductsServiceJoin usInvestor relationsContact us